Document is current
Any future updates will be listed below
-
Authors
Salerno, Nadia
Ielapi, Jessica
Cersosimo, Angelica
Leo, Isabella
Di Costanzo, Assunta
Armentaro, Giuseppe
De Rosa, Salvatore
Sciacqua, Angela
Sorrentino, Sabato
Torella, Daniele
-
Funding
Funding for this research was provided by:
Ministero dell'Università e della Ricerca (PNRR—National Center for Gene Therapy and Drugs based on RNA Technology No. CN00000041, PNRR—National Center for Gene Therapy and Drugs based on RNA Technology No. CN00000041, PNRR—National Center for Gene Therapy and Drugs based on RNA Technology No. CN00000041)
Ministero della Salute (POS4 “Cal-Hub-Ria” No. T4-AN-09; PNRRMAD-2022-12376814)
- License Information
-
More Information
Article History
Received: 18 February 2025
Accepted: 20 March 2025
First Online: 26 March 2025
Declarations
:
: The study was approved by the Local Ethics Committee (Protocol Register No. 170, May 30, 2024). All patients provided written informed consent before participating in the study.
: All authors listed above approved the manuscript for publication.
: The authors declare no competing interests.
